Similar to sPD-L1, serum-derived exoPD-L1 may be elevated in patients with increased systemic inflammation provoked by the inflammatory tumor type of pancreatic cancer [22]. This evidence concerns the gene SPDL1 and familial pancreatic carcinoma.